Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 28;16(6):e0253365.
doi: 10.1371/journal.pone.0253365. eCollection 2021.

The diagnostic value of skin biopsies in Sneddon syndrome

Affiliations

The diagnostic value of skin biopsies in Sneddon syndrome

N L P Starmans et al. PLoS One. .

Erratum in

Abstract

Background: Sneddon syndrome (SS) is defined by widespread livedo reticularis (LR) and stroke. There is no single diagnostic test for SS and diagnosis can be solely based on clinical features. This cross-sectional case-control study aimed to determine the diagnostic value of skin biopsies in SS patients.

Materials and methods: We studied skin biopsies from patients with a clinical diagnosis of SS or isolated LR. We also studied controls with vitiligo or normal skin. Biopsies were considered standardized if 3 biopsies were taken from the white centre of the livedo and reached until the dermis-subcutis border. Biopsies were scored for features of an occlusive microangiopathy without knowledge of the clinical features. Sensitivity and specificity of the biopsy findings were calculated with the clinical criteria as the reference standard.

Results: We included 34 SS patients, 14 isolated LR patients and 41 control patients. Biopsies of 17 patients with SS (50%), 4 with isolated LR (31%) and 10 control patients (24%) showed at least one artery in the deep dermis with a thickened vessel wall combined with recanalization or neovascularization (sensitivity 50% and specificity 69% with LR as reference). Standardized biopsies increased the sensitivity to 70%. In a post hoc analysis the combination of an occlusive microangiopathy and the presence of a livedo pattern in the superficial dermis increased the specificity to 92%.

Conclusions: Standardized skin biopsies can support the clinical diagnosis of SS. An occlusive microangiopathy as the only positive criterion for the diagnosis of SS had insufficient specificity for a definite diagnosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Livedo reticularis.
This figure shows an example of a patient with Sneddon syndrome with livedo reticularis on the right arm. This patient also had livedo reticularis on the legs, trunk, buttocks and face.
Fig 2
Fig 2. Example one of a probable occlusive microangiopathy.
(A) Low magnification shows that the abnormal arteries are located in the deep dermis (box) (H&E, 25x). (B) In detail, multiple arteries with a patent lumen and a thickened vessel wall, suggesting neovascularization (H&E, 100x).
Fig 3
Fig 3. Example two of a probable occlusive microangiopathy.
(A) Low magnification shows that the abnormal arteries are located in the deep dermis (box) (H&E, 20x). (B) In detail, extensive neovascularization (*) and recanalization (^) are visible (H&E, 200x).
Fig 4
Fig 4. Example of a livedo pattern.
The right side of the biopsy shows a normal superficial dermis. On the left side of the biopsy, a livedo pattern is visible (arrow). There are more arteries in the superficial dermis, which are more horizontally arranged (H&E, 50x).

References

    1. Sneddon I. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol. 1965; 77: 180–185. doi: 10.1111/j.1365-2133.1965.tb14628.x - DOI - PubMed
    1. Wu S, Xu Z, Liang H. Sneddon’s syndrome: A comprehensive review of the literature. Orphanet J Rare Dis. 2014; doi: 10.1186/s13023-014-0215-4 - DOI - PMC - PubMed
    1. Francès C, Papo T, Wechsler B, Laporte JL, Biousse V, Piette JC. Sneddon syndrome with or without antiphospholipid antibodies: A comparative study in 46 patients. Medicine (Baltimore). 1999; 78: 209–219. doi: 10.1097/00005792-199907000-00001 - DOI - PubMed
    1. Bottin L, Francès C, De Zuttere D, Boëlle PY, Muresan IP, Alamowitch S. Strokes in Sneddon syndrome without antiphospholipid antibodies. Ann Neurol. 2015; 77: 817–829. doi: 10.1002/ana.24382 - DOI - PubMed
    1. Starmans NLP, van Dijk MR, Kappelle LJ, Frijns CJM. Sneddon syndrome: a comprehensive clinical review of 53 patients. J Neurol. 2021; doi: 10.1007/s00415-021-10407-x - DOI - PMC - PubMed